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Sitosterolemia is a rare autosomal recessive disorder characterized by (a) intestinal hyperabsorption of all sterols,
including cholesterol and plant and shellfish sterols, and (b) impaired ability to excrete sterols into bile. Patients
with this disease have expanded body pools of cholesterol and very elevated plasma plant-sterol species and
frequently develop tendon and tuberous xanthomas, accelerated atherosclerosis, and premature coronary artery
disease. In previous studies, we have mapped the STSL locus to human chromosome 2p21. Recently, we reported
that a novel member of the ABC-transporter family, named “sterolin-1” and encoded by ABCG5, is mutated in 9
unrelated families with sitosterolemia; in the remaining 25 families, no mutations in sterolin-1 could be identified.
We identified another ABC transporter, located !400 bp upstream of sterolin-1, in the opposite orientation. Mu-
tational analyses revealed that this highly homologous protein, termed “sterolin-2” and encoded by ABCG8, is
mutated in the remaining pedigrees. Thus, two highly homologous genes, located in a head-to-head configuration
on chromosome 2p21, are involved as causes of sitosterolemia. These studies indicate that both sterolin-1 and
sterolin-2 are indispensable for the regulation of sterol absorption and excretion. Identification of sterolin-1 and
sterolin-2 as critical players in the regulation of dietary-sterol absorption and excretion identifies a new pathway
of sterol transport.
Introduction
The hypothesis that dietary-cholesterol absorption may
be regulated by a complex molecular mechanism was
first given credence with the seminal publication of a
clinical study 125 years ago; Bhattacharyya and Connor
(1974) studied two affected sisters who had presented
with arthralgias and tendon xanthomas but who did not
show the classic features of familial hypercholesterole-
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mia on biochemical testing. Those authors reported a
new disorder, characterized instead by very elevated
plant sterols, and named the disorder “b–sitosterolemia”
(MIM 210250), after the major species of plant sterol
that was elevated in the plasma of the two sisters. Al-
though this condition appears to be relatively rare, 140
families that have it have been reported (Bjorkhem and
Boberg 1995; Patel et al. 1998b). Affected individuals
may present with tendon and/or tuberous xanthomas,
arthralgias, hemolytic anemia, and premature athero-
sclerotic disease (Bhattacharyya and Connor 1974; Hi-
daka et al. 1990; Salen et al. 1992; Bjorkhem and Boberg
1995). Affected individuals have significantly elevated
plasma levels of noncholesterol sterols of dietary origin,
which are mainly plant sterols, but with normal tomildly
elevated plasma cholesterol levels; shellfish sterols also
have been reported to be elevated (Gregg et al. 1986).
Phytosterols are normally almost undetectable in plasma
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Figure 1 Pedigrees with sitosterolemia. The parents, who are depicted as obligate carriers (half-black symbols), and the affected individuals
(black symbols) are indicated. Only one of these pedigrees, 3400, is consanguineous. The boxed pedigrees are those that are mutant for sterolin-
1 (see the Results section).
Table 1
Intron/Exon Boundaries for ABCG8
GENBANK
ACCESSION
NUMBER
EXON INTRON EXON
Number
Size
(bp) 3′-End Sequence Splice-Donor Site Number
Size
(bp) Splice-Acceptor Site 5′-End Sequence Number
AF351812 1 153 CCCCAGGATACCTCG gtgagtgagcaatgg 1 5,486 tcctgtctcccacag GGCCTCCAGGATAGA 2
AF351813 2 102 GACCTCAACTGCCAG gtagaggcacgcctg 2 1,546 gatatctccccacag GTGGACCTGGCCTCT 3
AF351814 3 157 TCATAGGGAGCTCAG gtaccggaaaggcaa 3 ∼6,000 ctggtggctttgcag GTTGTGGGAGAGCCT 4
AF351815 4 239 CAGCGTGACAAAAGG gtaactaactggccc 4 531 ccttctggcccacag GTGGAAGACGTGATC 5
AF351816 5 133 TCCTGTGGAACCCAG gtgagggcctggggg 5 112 ctctgtgttggaaag GAATCCTTATTGTCG 6
AF351817 6 270 CTGCTGACTTCTATG gtgagtccccaaggc 6 140 kb? TGGACCTGACCAGCA 7
AF351818 7 163 CACCTGTGTGGAAAG gtaaggtggcaggcg 7 87 tctgcctcccagcag CGTGACCCCACTAGA 8
AF351819 8 81 TAAGACGCTGATCCG gtaattatctgtcat 8 ∼1,000 cttttggtttttaag TCGTCAGATTTCCAA 9
AF351820 9 201 ATGTCATCTCCAAAT gtgagtgtggcccac 9 419 tcccttactttttag GTTACTCAGAGAGGG 10
AF351821 10 77 TATTTCTTTGCCAAG gtgactgggcagggt 10 665 ggctgttctttgcag ATCCTCGGGGAGCTT 11
AF351822 11 268 GCAGCCTGTGGACAG gtaaggcctgccccc 11 ∼1,600 gctgtctgtctccag TGCCCGCGTGGATTT 12
AF351823 12 128 GTCTCAGGAGATAAA gtaagcggggaaggc 12 87 tgtctgtgtctccag ATCCTCAGTGCCATG 13
AF351824 13 672 ATGTATTGAGCATCT
from normal individuals (Bjorkhem and Boberg 1995;
Patel et al. 1998b). Indeed, previous studies had estab-
lished that plant sterols were excluded from the body,
despite being present, in the normal diet, in equal
amounts almost to those of cholesterol (Gould et al.
1969). Almost no sitosterol was absorbed in normal in-
dividuals, and this finding has been reproduced in other
mammals, suggesting that the exclusion of noncholes-
terol sterols may be more universal (Kuksis and Huang
1962; Ikeda et al. 1988). Studies 150 years ago had
shown that sitosterol, when administered orally, inter-
fered with dietary-cholesterol absorption; and sitosterol
was used as the first therapeutic modality for hypercho-
lesterolemia, prior to the advent of potent hypolipidemic
agents (Pollock 1953; Best et al. 1955; Farquhar et al.
1956). That a single gene, when disrupted, led to the
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Figure 2 A, Structure and organization of ABCG5 and ABCG8. The intronic sizes (see table 1) were estimated on the basis of either
long-range PCR products or, when available, genomic sequence. B, Promoter-region DNA sequence between the two first exons of each gene.
The minimum start-transcription sites were estimated on the basis of both the presence of particular sequences in cDNA and the ability of an
oligonucleotide located in such sequences to amplify spliced cDNA sequences. We estimate that the maximum distance between the two genes’
start-transcription sites is 140 bp. No canonical TATA sequence can be identified in this minimal region.
loss of sterol selectivity in dietary-sterol absorption and
was associated with accelerated atherosclerosis sug-
gested that specific molecular mechanisms regulate this
pathway (Salen et al. 1992; Patel et al. 1998a). Clinical
and laboratory studies suggested that the liver normally
rapidly excretes into bile any noncholesterol sterols that
are introduced into the bloodstream and that this process
is also deficient in patients with sitosterolemia (Salen et
al. 1992). Bile from affected individuals was found to
be very cholesterol poor, suggesting that the same gene
that is responsible for selective sterol absorption from
the intestine may also mediate the excretion of choles-
terol into bile. Recently, the STSL locus has beenmapped
to chromosome 2p21 (Patel et al. 1998b) and has been
further localized to a !2-cM region bounded by markers
D2S2294 and D2S2291 (Lee et al. 2001a).
We isolated the entire sitosterolemia critical region in
a sequence-ready bacterial artificial chromosome (BAC)
contig and built a transcript map of this region (Lu et
al. 2001). A number of expressed sequence tags (ESTs)
and genes were mapped in the region of interest. One of
these was found to encode a “half-ABC” transporter,
ABCG5/sterolin-1 (MIM 605459), and also was found
to be mutated in nine families with sitosterolemia (Lee
et al. 2001b ; Shulenin et al., in press). Examination of
two other ESTs (GenBank accession numbers AA034046
and AA700586) showed they were derived from a single
cDNA and encoded a highly homologous protein, ster-
olin-2. The gene for sterolin-2 has been assigned the name
“ABCG8” (MIM 605460). Mutational analyses showed
that sterolin-2 was mutated in the remaining 25 pro-
bands. Thus, defects in either of two related genes are
responsible for causing sitosterolemia. Berge et al. (2000)
also have reported that mutations in ABCG8 cause si-
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Figure 3 Alternative splicing of ABCG8 mRNA transcripts. The genomic sequence of exon 7–exon 8 region is shown (A), with the splice-
acceptor site for exon 8, which contains a CAG repeat (underlined) that results in two different processed transcripts being made. The majority
of clones are spliced by the first AG (B, left), but ∼10% of transcripts are spliced by the second AG (A, downward-facing arrowhead).
tosterolemia. We report here the characterization of the
genomic structure of this region, a compendium of mu-
tations in one of the largest collections of affected indi-
viduals known worldwide. We also provide genetic evi-
dence that the products of ABCG5 and ABCG8—
sterolin-1 and sterolin–2, respectively—either may func-
tion as heterodimers or are tightly coupled in a pathway
regulating dietary-sterol absorption and excretion.
Families and Methods
Pedigrees
All pedigrees (fig. 1) were recruited on the basis of
criteria defined elsewhere (Patel et al. 1998a, 1998b).
Clinical features of some of the probands and their fam-
ily members also have been described elsewhere (Patel
et al. 1998a, 1998b). In brief, all probands had (a) clin-
ical features compatible with a diagnosis of sitostero-
lemia and (b) diagnostically elevated plasma sitosterol
levels. The pedigrees include 6 Japanese families (700,
800, 2100, 2800, 3300, 3500, and 3700), 2 South Af-
rican families of Asian origin (500 and 3600) and 1
South African family of white origin (family 600), 16
U.S. white families (100, 200, 300, 1000, 2000, 2200,
2300, 2400, 2600, 2700, 3000, 3100, 3200, 4000,
4200, and 4300), 1 U.S. African-American family
(3800), 1 Dutch family (2500), 1 Norwegian family
(2900), 2 Finnish families (400 and 3900), 1 Swedish
family (4100), 1 French family (4400), and 1 Colombian
family (3400). The only known consanguineous family
is family 3400. Many of the probands reported by Berge
et al. (2000) are also part of the present study. Informed
consent was obtained from all participants, in accor-
dance with local institutional-review-board guidelines.
These families include the original index cases (in ped-
igree 2300) as well as two Amish-Mennonite families
(pedigrees 2200 and 2700).
Isolation of Full-Length cDNA and Gene-Structure
Characterization
After fine mapping and construction of a BAC-and-
YAC contig across the region of interest, we mapped a
number of genes and cDNAs onto this contig (Lee et al.
2001a; Lu et al. 2001). Three ESTs were identified
(GenBank accession numbers AA700586, AA034046,
and T99836). One of these, T99836, encoded the
ABCG5/sterolin. ABCG5 was found to be mutated in
nine families (Lee et al. 2001b). The two other ESTs
were used to screen cDNA libraries from the human liver
and intestine, and nine clones were identified and se-
quenced. On the basis of sequence analyses, we were
able to infer that both ESTs were part of a single cDNA
and that they encoded another ABC-family member.
This gene, encoding sterolin-2, was assigned the name
“ABCG8, according to the HUGO nomenclature.
Image clones corresponding to ESTs that mapped to
the region of interest were obtained from Research Ge-
netics and were fully sequenced. Probes were generated
and used to screen both phage lambda and plasmid hu-
man liver and intestine cDNA libraries (Clontech and
Stratagene). All positive clones were screened for insert
sizes, and the longest clones were fully sequenced. A
cDNA clone of size 2.4 kb was identified that contained
exons 4–13 of sterolin-2 cDNA. To identify the 5′ end
of the cDNA, RACE was undertaken, with total RNA
obtained from the human liver, as well as with com-
mercially available cDNA (Origene). Additionally, we
screened a genomic library made from HindIII-digested
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Figure 4 Homology of human, mouse, and rat ABC proteins. A, Phylogenetic analyses of sterolins and other ABC proteins, performed
as described in the text. Each ABC-family member was included on the basis of identification based on its ATP-binding domain and the inclusion
of ∼10 amino acids upstream and 120 amino acid downstream of this site. For ABC proteins that contain two ATP-binding sites, each site was
analyzed independently; the first site is represented by the thinner unbroken lines, the second site by broken lines. Reassuringly, all such proteins
clustered, indicating that such “full” ABC proteins are closely related and probably evolved after being organized as full ABC proteins. Sterolin,
which forms a distinct family, is represented by the thicker unbroken lines; its nearest neighbor is the WHITE gene family, the mammalian
homologues of which include ABC8-family members. B, Human, mouse, and rat sterolin proteins, aligned by CLUSTALW. The Walker A (i.e.,
ATP-binding domain) and Walker C motifs are indicated by the series of downward-pointing black triangles and the series upward-pointing
black triangles, respectively; the Walker B motif is indicated by the sequence of alternating upward- and downward-pointing black triangles.
The thick horizontal lines indicate the predicted transmembrane domains. Residues with the highest homology are denoted by the black portions
of the boxes, those with moderate homology by the unblackened boxes and portions of boxes. Missense mutational changes are indicated by
black ovals and diamonds, and polymorphic coding changes are indicated by the unblackened ovals and diamonds; changes pertaining to
sterolin-1 (ABCG5) are indicated, above the alignments, by diamonds, and those pertaining to sterolin-2 (ABCG8) are indicated below the
alignments, by ovals. In sterolin-2, serine 376, which is deleted by alternative splicing, is indicated by the solitary upward-pointing triangle;
phenylalanine 570, which is deleted by a 3-bp deletion, is indicated by the arrow (see the text).
BAC clone R-328I4 with a probe containing exon 1 of
ABCG5 sequences. A 4.9-kb fragment was identified
that contained exons 1 of both ABCG5 and ABCG8
and that was completely sequenced from both ends. Us-
ing oligonucleotides based on this information, we were
able to amplify exons 1–3 from cDNAs and RACE ex-
periments and, thereby, were able to determine the full-
length cDNA for human sterolin-2. The gene structure
was characterized by PCR with BAC genomic DNA as
the template. A list of the oligonucleotides used for exon
amplification and of the approximate intron sizes is pre-
sented in table 1. Intron 6 acceptor-site boundary se-
quence is currently not available.
Exon Amplification and DNA Sequencing
Exons were amplified by PCR using oligonucleotide
primers that are located within the flanking intronic ar-
eas (table 1) and that have been described elsewhere (Lee
et al. 2001b). SSCP variants were identified by incor-
poration PCR-SSCP (IPS), as described elsewhere (Sos-
sey-Alaoui et al. 1999). Direct sequencing of PCR prod-
ucts was performed by an Amplicycle sequencing kit
(Perkin Elmer), and the products were analyzed by an
ABIPRISM 377 Genetical Analyzer (Perkin Elmer). Both
strands were sequenced, to confirm the identified mu-
tations. Sequence alignment was aided by the use of
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MacVector software (Oxford Molecular) running on an
Apple iMac. PCR products were digested with appro-
priate restriction enzymes and were analyzed by agarose-
or acrylamide-gel electrophoresis (Yu et al. 2000).
Expression Analyses
Northern analysis was performed as described else-
where (Wu et al. 1999). A ready-made blot (Clontech)
was utilized for northern analyses of the humanABCG8
gene, under conditions specified by the manufacturer.
Additionally, reverse transcriptase–PCR (RT-PCR) anal-
yses were performed with commercially available ge-
nomic DNA-free cDNAs (Origene) and forward (MF2
[5′-ATGAACTGGAAGACGGGC]) and reverse (MR5
[5′-TGAAGGGTCTGCTCAG]) oligonucleotides locat-
ed in exons 10 and 13, respectively, yielding a cDNA
PCR product of 637 bp. Amplification of a b-actin
cDNA segment, by oligonucleotides provided by the
manufacturer (Origene), was used as a positive control.
Sequence Alignments and Phylogenetic Analyses
Sterolin protein sequences were aligned with other
ABC-transporter proteins, by CLUSTAL W (version 1.7)
(Thompson et al. 1994). ABC-protein sequences included
in the alignment were based on a variety BLAST and
TFASTX (Genetics Computer Group, Madison) searches
of databases. To ensure comparison of ABC proteins that
included half-transporters (i.e., proteins such as sterolins)
to ABC proteins that contain two ATP-binding sites and
ABC motifs, alignment was performed by identification
of the ATP-binding site, selection of ∼10 amino acids
upstream through 120 amino acids downstream of this
site, and analysis of each such segment independently.
Thus, ABC1, which has two such segments, is represented
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Figure 5 Northern analyses of human sterolin-2 expression. A, Tissue expression of sterolin, analyzed by hybridization to poly (A)
RNA from different human tissues. The upper panel shows that significant hybridization was detected for liver RNA only (lane 8) and not in
small-intestine RNA (lane 9); the bottom panel shows hybridization to b-actin after the membrane has been stripped. B, Results of RT-PCR
analyses of cDNAs from different human tissue types, suggesting that sterolin-2 transcripts can be detected in a number of different tissue types,
including the small intestine (top panel). The PCR products are derived from amplification across exons. Amplification of a control transcript,
b-actin, also is shown (b). NC p water-only control.
twice, the two segments designated by the suffixes “-1”
and “-2.” The alignment was assessed with 1,000 boot-
strap resamplings by the integral options of CLUSTAL
W. In addition, the alignment was subjected to the heu-
ristic bootstrap-analysis option of the maximum-parsi-
mony program PAUP (version 4.0) (Swofford and Olsen
1996). A further bootstrap resampling was performed by
the protein-distance programs of the PHYLIP package
(version 3.5c) (Felsenstein 1996). The trees produced by
the programs were transferred to TreeView version 1.5
(Page 1996), for manipulation and printing.
Results
Gene Structure and Expression Pattern of Sterolin-2
The gene structure for sterolin-1 and sterolin-2 was
characterized (fig. 2). Exons 1 and 2 of ABCG5 and
ABCG8 are located on a single BAC, C-569J16, that is
∼80 kb, and thus these two genes are located in close
proximity but are transcribed in opposite directions.
Note that the two initiator ATGs of the two respective
genes are separated by 340 bp only, and we estimate
that the start-transcription sites are140 bp apart (data
not shown). The exact start-transcription sites have not
been accurately determined. When reverse oligonucleo-
tides located in either exon 3 or exon 4 were used, RT-
PCR yielded specific products. Overlapping oligonu-
cleotides only 10 bp upstream of these failed to yield a
PCR product (data not shown), suggesting that the start-
transcription sites are very close to these areas. Although
the mouse homologous sequence contains one TATAbox
(K. Lu, M.-H. Lee, and S. B. Patel, unpublished data),
none was identified in the human “promoter” sequence.
Sequence analyses of several sterolin-2 cDNA clones
showed that a few clones had a CAG codon deleted,
with the loss of serine 376. This position corresponds
to the boundary of exons 7 and 8. Examination of the
genomic sequence both showed that the splice-acceptor
site at exon 8 contained two CAGs in tandem and sug-
gested alternative splicing as a source of this apparent
“polymorphism” (fig. 3). To confirm this, we isolated
RNA from the human liver and, after RT-PCR and clon-
ing of cDNA fragments, sequenced 20 clones at random.
Approximately 10% of the cDNAs contained a deletion
of the CAG and would result in the deletion of serine
376. The functional consequences of this deletion in a
minority of ABCG8 transcripts are not known.
Phylogenetic analyses of sterolin-2 showed it to be
highly homologous to sterolin-1 and placed it firmly
within the ABCG family (fig. 4A). Comparison of the
mouse, rat, and human proteins showed a very high de-
gree of conservation, with 185% similarity at the peptide
level (fig. 4B). Both sterolins contain the characteristic
ABCmotifs, located at theN-terminal half, with predicted
six transmembrane domains located at the carboxyl-ter-
minal end (fig. 4B). Although sterolin-1 contains two po-
tential N-glycosylation signals in the largest lumenal fac-
ing loop, only one such potential site is present in sterolin
2 (fig. 4B). A number of mutations were identified in both
ABCG5 and ABCG8 (see below), and the positions of
the missense mutations are as indicated in fig. 4B.
We have previously reported the expression pattern for
murine ABCG5 mRNA (Lee et al. 2001b). A human full-
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Table 2
Compilation of Mutations in ABCG5 and ABCG8
PATIENT (NATIONALITY/ETHNICITY)
MUTATIONS IN
ABCG5a ABCG8b
4 (U.S./white) Trp361X (1173GrA) / Arg412X (1324CrT)
9 (U.S./white) Arg543Ser (1719GrT) / Gln172X (604CrT)
56c (U.S./white) Trp361X (1173GrA) / Tyr658X (2064CrG)
60 (U.S./white) Trp361X (1173GrA) / IVS1 2 ArG
90c (U.S./white) Trp361X (1173GrA) / Trp361X (1173GrA)
94 (U.S./white) Trp361X (1173GrA) / Arg184His (641GrA)
120 (U.S./white) Trp361X (1173GrA) / Leu501Pro (1592TrC)
125 (U.S./white) Trp361X (1173GrA) / Trp361X (1173GrA)
128 (U.S./white) Leu596Arg (1877TrG) / IVS1 2 ArG
172 (U.S./white) Trp361X (1173GrA) / Tyr658Stop (2064CrG)
166c (U.S./white) Trp361X (1173GrA) / Arg412X (1324CrT)
32 (SA/white) Arg121X (451CrT) / Arg121X (451CrT)
98 (Dutch/white) Trp361X (1173GrA) / Gly574Glu (1811GrA)
102c,d (U.S./white) Trp361X (1173GrA) / …
84c (U.S./Amish-Mennonite) Gly574Arg (1810GrA) / Gly574Arg (1810GrA)
108c (U.S./Amish-Mennonite) Gly574Arg (1810GrA) / Gly574Arg (1810GrA)
135 (Columbian/white) Trp536X (1698GrA) / Trp536X (1698GrA)
175 (French) 1798_1800delTTC / Arg405His (1304GrA)
20 (Finnish) Trp361X (1173GrA) / Trp361X (1173GrA)
154 (Finnish) Trp361X (1173GrA) / …
116 (Norwegian) Trp361X (1173GrA) / Trp361X (1173GrA)
163 (Swedish) Trp361X (1173GrA) / Leu572Pro (1805TrC)
15 (U.S./white) 1568_1572delTCTTT / IVS1 2 ArG
143 (SA/Asian) Arg164X (580CrT) / Arg121X (451CrT)
25 (SA/Asian) Arg243X (876CrT) / Arg243X (876CrT)
40 (Japanese) Arg419His (1396GrA) / Arg419His (1396GrA)
46 (Japanese) Arg389His (1306GrA) / Arg389His (1306GrA)
63 (Japanese) del exon 3 / del exon 3
113 (Japanese) Arg389His (1306GrA) / Arg389His (1306GrA)
132 (Japanese) Arg419His (1396GrC) / Arg550Ser (1790ArC)
140 (Japanese) Arg408X (1362CrT) / Arg408X (1362CrT)
146 (Japanese) Arg389His (1306GrA) / Arg389His (1306GrA)
157 (U.S./white) Arg419Pro (1396GrC) / Arg419Pro (1396GrC)
149 (African American) Glu146Gln (576GrC) / …
1c,e (German/Swiss) Trp361X / Trp361X
2c,e (U.S./Amish) Gly574Arg / Gly574Arg
3c,e (U.S./white) Trp361X / Tyr658X
5c,d (U.S./white) Trp361X / Arg412X
6c,e (U.S./white) Leu596Arg / …
7d (U.S./Hispanic) Arg412X / del547Cr191X
8c,e (New Zealand/white) Trp361X / …
4e (Chinese) Arg263Gln / Pro231Thr
9e (Chinese) Arg408X / …
a GenBank accession number AF312715.
b GenBank accession number AF324494.
c Proband is common to both the present study and that by Berge et al. (2000).
d Although described by Berge et al. (2000) as originating from New Zealand, this proband is of U.S./white origin.
e Proband reported by Berge et al. (2000).
length ABCG8 (sterolin-2) cDNA was used to probe a
multiple-tissue northern filter, and the results of this are
shown in figure 5. Northern analyses show robust ex-
pression in the human liver only, although, in RT-PCR
analyses (fig. 5B), expression is detectable in a wide va-
riety of human tissues. Since the forward and reverse
primers used for RT-PCR are located in exons 10 and 13,
respectively, genomic contamination is unlikely. Since RT-
PCR is considerably more sensitive than are northern
analyses, the implication is that sterolin-2 is more widely
expressed, albeit at low levels. Confirmation of this wider
expression at the protein level is pending development of
antibody reagents. This is in contrast to murine sterolin-
1 whose mRNA expression, by both northern and RT-
PCR analyses, appears to be confined to the liver and
intestine (Berge et al. 2000; Lee et al. 2001b).
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Table 3
Frequency of Mutant Alleles in ABCG5 and ABCG8
Gene and Mutation
No. of
Alleles Frequency
Restriction-
Enzyme
Recognition
ABCG5:
Glu146Gln 1 .05 Gain of AlwNI
Arg243X 2 .10 Gain of AlwNI
Arg389His 6 .30 Loss of BstUI
Arg408X 3 .15 Loss of AvaI
Arg419Pro 2 .10 Loss of BstUI
Arg419His 3 .15 Loss of BstUI
del exon 3 2 .10 …
Arg550Ser 1 .05 …
Total 20
ABCG8:
Arg121X 3 .061 Gain of DdeI
Arg164stop 1 .020 …
Gln172X 1 .020 Gain of BfaI
Arg184His 1 .020 Gain of NalIII
Pro231Thr 1 .020 Loss of NlaIV
Arg263Gln 1 .020 Gain of AluI
Trp361X 19 .39 …
Arg405His 1 .020 …
Arg412X 3 .061 Gain of DdeI
Leu501Pro 1 .020 Loss of AluI
Trp536X 2 .041 Gain of AhdI
Arg543Ser 1 .020 …
Leu572Pro 1 .020 Gain of FauI
Gly574Glu 1 .020 Loss of MspI
Gly574Arg 4 .082 Loss of MspI
Leu596Arg 1 .020 Gain of MspI
Tyr658X 2 .041 Gain of SfcI
IVS1 2ArG 3 .061 Gain of BtgI
1798_1800delTTC 1 .020 …
1568_1572delTCTTT 1 .020 …
Total 49
Mutations of Sterolin-2/ABCG8 as the Cause of
Sitosterolemia
Information on the exon/intron boundaries was used
to screen probands, including those known to be mu-
tated for sterolin-1, and to compare them to normal
controls. All SSCP variants were sequenced, and any
nucleotide changes were compared for evidence of mu-
tations. No proband previously found to be mutated for
ABCG5/sterolin-1 (fig. 1, boxed pedigrees) was found to
harbor nucleotide changes compatible with mutations in
ABCG8/sterolin-2. To confirm that these changes are mu-
tations, segregation analyses, using restriction-enzyme di-
gestions when possible, were performed (data reviewed
but not shown). All mutational changes were also
screened in appropriate control samples of the respective
populations, including individuals from the United States
( ), Finland ( ), and Japan ( ). Nonenp 69 np 95 np 82
of the mutational changes described were seen in the con-
trol samples. A compilation of all the mutations identified
is given in table 2, including those reported elsewhere
(Berge et al. 2000; Lee et al. 2001b). In three probands
(102, 149 and 154), only a single mutation was identified.
Table 3 shows a compilation of the frequency of each
mutation identified thus far. Surprisingly, Trp361X is the
most common mutation in sterolin-2, and Arg389His is
the most common mutation in sterolin-1. The positions
of the missense and coding polymorphic changes are in-
dicated in the homology alignment (see fig. 4B). Of in-
terest is a 3-bp deletion in the fourth transmembrane do-
main of sterolin-2, resulting in the loss of phenylalanine
570; this deletion is located next to two other missense
mutations but also is adjacent to a missense polymor-
phism (Gly575Arg) that does not appear to be deleterious
(fig. 4B).
A number of polymorphic changes, both silent and
nonsilent, also were identified. These were found both
in normal controls (table 4) and in some of the probands,
parents, and unaffected siblings (data not shown).
We examined whether being mutant sterolin-1 or mu-
tant sterolin-2 resulted in a difference in plasma sitos-
terol levels (fig. 6). When the affected individuals were
grouped on the basis of whether they have mutant ster-
olin-1 or mutant sterolin-2, no differences in plasma
sitosterol levels were observed at diagnosis (fig. 6). Par-
ents or siblings were not segregated on the basis of
whether they are carriers for either of the mutant ster-
olins, since their plasma sitosterol levels are very close
to the detection range.
Discussion
Selectivity for sterol absorption, which is a feature dem-
onstrated in humans, rats, and dogs, may be more widely
present in mammals. On the basis of the deficiencies in
sitosterolemia, this pathway involves molecular mecha-
nisms operating in both the liver and the intestine, con-
trolling both sterol excretion into bile and selective sterol
absorption from the diet.
After localizing the sitosterolemia locus to human
chromosome 2p21, we identified two candidate genes,
designated “ABCG5” and “ABCG8,” encoding two
proteins—sterolin-1 and sterolin-2, respectively. These
encode for two half-ABC transporters, since they each
contain only 6 transmembrane domains, as opposed to
the 12 transmembrane domains that characterize many
of the ABC proteins (Klein et al. 1999). The term “trans-
porter” is used loosely, since this function has not been
formally assigned to these proteins.
Elsewhere (Lee et al. 2001b), we have reported that
ABCG5 was mutated in nine probands, a finding also
reported by (Berge et al. 2000), who, in addition, re-
ported mutations in ABCG8 in a selection of probands
with sitosterolemia, many of whom are also members of
the pedigrees used in the present study. We report here
a detailed characterization of a very large multiethnic
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Table 4
Polymorphisms Identified in ABCG5 and ABCG8
GENE
AND REGION
NUCLEOTIDE
(AMINO ACID) CHANGE
RESTRICTION-
ENZYME CHANGE
NO. OF IDENTIFIED
POLYMORPHISMS
HARDY-
WEINBERG
EQUILIBRIUM?/ / /
ABCG5:
167CrT (Pro9Pro) Gain of BstNI … … … …
1950CrG (Gln604Glu) Loss of SmlI 46 25 1 Yes
ABCG8:
Exon 1 141CrT (Pro17Pro) … 49 1 0 Yes
Exon 1 145GrC (Asp19His) Loss of BaeI 74 3 1 No
Exon 2 251GrA (Cys54Tyr) Gain of SexAI 21 23 23 No
Exon 6 802GrA (Glu238Lys) … 10 1 0 Yes
Exon 6 866CrT (Ala259Val) Loss of HaeIII 0 5 0 …
Exon 8 1289CrA (Thr400Lys) Gain of MseI 116 53 4 Yes
Exon 11 1785CrT (Ala565Ala) Loss of MnlI 20 7 1 Yes
Exon 11 1813GrC (Gly575Arg) Gain of HhaI 188 6 4 No
Exon 13 1984CrT (Ala632Val) Loss of StyI 107 50 13 No
5′ UTR 15ArC Gain of BstEII 47 4 0 Yes
5′ UTR 19TrG Loss of Tsp451 38 42 29 No
5′ UTR 41CrT Loss of DdeI 7 2 4 No
Intron 1 7CrT Loss of BsmAI 21 23 4 Yes
Intron 1 21CrA Loss of MnlI 20 23 4 Yes
Intron 9 19CrT … 1 3 4 …
Intron 10 IVS10 34delCC … 3 1 4 …
Intron 10 50CrT … 4 4 2 …
cohort of patients with sitosterolemia. Our analyses in-
dicate that all affected individuals, representing 37 fam-
ilies, carry a mutation in either ABCG5 or ABCG8 but
not in both. Clinically, there are no readily apparent fea-
tures that differentiate individuals mutated for sterolin-
1 versus those mutated for sterolin-2. We interpret these
data to suggest that these two proteins either act as func-
tional heterodimers or are tightly coupled along a path-
way that regulates dietary-sterol absorption. Thus, com-
plete loss of any of the sterolins will lead to a functional
deficiency. An individual who, hypothetically, carries a
mutation in one copy of ABCG5 and in one copy of
ABCG8 may not have sitosterolemia, since he or she
would be predicted to have25% normally functioning
sterolins. Consistent with this interpretation, the obligate
heterozygous parents of our probands do not appear to
manifest any clinical or biochemical features, although
they are predicted to have 50% normally functioning
sterolins. These predictions are amenable to both genetic
and biochemical testing.
All of the Japanese probands appear to havemutations
in ABCG5 only (Lee et al. 2001b). However, mutations
in ABCG5 are not exclusively limited to the Japanese:
one South African pedigree of Indian Asian origin and
one South African pedigree of U.S. white origin were also
found to be mutated in ABCG5. There is a very high
degree of homozygosity for informative markers around
the STSL locus in many of our probands, despite the
presence of only one known consanguineous marriage
(Lee et al. 2001a). Additionally, there is robust evidence
for linkage disequilibrium (Lee et al. 2001a). Elsewhere
(Lee et al. 2001a), we have hypothesized that the mu-
tations giving rise to sitosterolemia are very old, perhaps
11,800 years. Two mutations—Arg389His in ABCG5
and Trp361X inABCG8—are very common. Arg389His
is found only in the Japanese population, although we
did not detect this mutation a random sample of 82 Jap-
anese subjects. In this context, it is noteworthy that more
individuals had ABCG8 mutations than had ABCG5
mutations. An additional observation is that ABCG8 is
more polymorphic than ABCG5, despite the relative
proximity of these two genes and their apparent mutual
requirement for function. Thus, if founder effects are re-
sponsible for some of the sitosterolemia mutations, the
disparate nature of polymorphisms in ABCG8—but not
in ABCG5—is difficult to explain at present.
The structure of ABCG5/ABCG8 is also worthy of
comment. Although the exact start-transcription site for
either gene has not been identified definitively, both on
the basis of the presence of sequences in the cDNAs and
by comparison to rodent cDNAs, the distance separating
the two start-transcription sites is 140 bp. These 140
bp do not contain a canonical TATA box, nor do they
identify any motifs that suggest promoter sequences. The
functioning of this promoter may be unique, especially
if sterolins are functional heterodimers, and may need to
be expressed coordinately. Berge et al. (2000) identified
ABCG5 and ABCG8 as genes that showed alteration in
RNA abundance after exposure to LXR agonists, and it
is noteworthy that Repa et al. (2000) showed that ma-
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Figure 6 Effect of mutations, in either ABCG5 or ABCG8, on
plasma sitosterol levels. Plasma sitosterol levels were grouped on the
basis of whether affected individuals had mutant sterolin-1 (ABCG5)
or mutant sterolin-2 (ABCG8) and were compared with those in their
parents (obligate heterozygotes), in their unaffected siblings, and in
controls. Plasma sitosterol levels in individuals with mutant sterolin-
1 were not different from those in individuals with mutant sterol-2.
nipulation of the LXR pathway modulates cholesterol
absorption. Thus at least one transcriptional activator of
these genes may be the LXR-RXR heterodimers. If con-
firmed, this may be a link to the coordinate regulation
of both the bile acid–biosynthesis pathway and the sterol-
absorption and sterol-excretion pathways.
We identified an alternatively spliced form of
ABCG8, resulting from of a CAG repeat at the 3′ splice-
acceptor site at the intron 7/exon 8 boundary. Although
this type of splice site is very unusual, it is not without
precedent. Three genes with similar behavior have been
reported; CD3z, the gene for insulin-like growth fac-
tor–receptor 1 (IGFRI), and the Hoxd-11 gene have
been shown to have, at the intron/exon boundaries, a
CAGCAG repeat that results in both alternative splicing
and the presence or absence of an extra amino acid (Yee
et al. 1989; Moingeon et al. 1990; Rogina and Upholt
1995). To date, no functional consequences of such al-
terations have been reported. Smith et al. (1993) have
suggested that the 3′ splice-site selectionmechanismmay
involve scanning for the presence of AGs—and, thus,
that the presence of two adjacent CAGs at the intron/
exon boundary results in the inclusion/exclusion of a
triplet codon. Mouse ABCG8 mRNA—and, perhaps,
rat ABCG8 mRNA—also shows a similar alternative
splicing pattern (K. Lu, M.-H. Lee, and S. B. Patel,
unpublished data).
Recently, a number of other gene products have been
implicated as playing a role in dietary-cholesterol trans-
port. Repa et al. (2000) have suggested that ABC1 may
play a crucial role, on the basis of (a) high levels of gene
transcription in intestinal RNA of animals treated with
LXR agonists and (b) correlative studies in which cho-
lesterol absorption in LXR-deficient or agonist-treated
animals was altered. Interestingly, Berge et al. (2000)
had identified ABCG5 and ABCG8 as part of a screen
for genes whose expression was altered by LXR-agonist
treatments. We suggest that, in the experiments by Repa
et al., expression of ABCG5/ABCG8 was altered and
that the robust expression of ABC1 seen in their studies
could be explained by expression in nonenterocytes,
such as fibroblasts and lymphoid cells in the intestinal
wall, but not the enterocytes. Lawn et al. (2001) have
recently examined the expression of ABC1 by in situ
expression in normal mouse tissues, and their data
would support our interpretation. Whether enterocytes
specifically express ABC1 after LXR activation has not
been reported. Another protein implicated as playing a
role is scavenger receptor 1 (SR-B1) (Hauser et al. 1998;
Schulthess et al. 2000). There are both biochemical and
localization data that support the role of SR-B1 in di-
etary-cholesterol absorption. It is unclear, however,
whether the role of SR-B1 is limited to helping to off-
load the sterol contents of the micelles that attach to
the lumenal enterocytes or whether it also plays a role
in regulating the types of sterols that are allowed to
enter the enterocyte. That SR-B1 is not absolutely re-
quired for this process but may play a facilitatory role
is supported by data from mice deficient in SR-B1 (Mar-
dones et al. 2001). Such mice do not appear to manifest
any deficiencies in dietary-cholesterol absorption.
Sterolins are likely involved both in the selective
transport of dietary cholesterol in and out of enterocytes
and in selective sterol excretion by the liver into bile,
as evidenced by the consequences when it is deficient
(Salen et al. 1992). The identification of these proteins
now provides strong evidence for the hypothesis that
dietary-cholesterol absorption is both selective and con-
trolled by molecular mechanisms. Further study of the
specific mechanisms by which these processes occur will
be greatly facilitated by the identification of the genes
found to be mutated in sitosterolemia.
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